These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16140970

  • 1. SRC-3 is required for prostate cancer cell proliferation and survival.
    Zhou HJ, Yan J, Luo W, Ayala G, Lin SH, Erdem H, Ittmann M, Tsai SY, Tsai MJ.
    Cancer Res; 2005 Sep 01; 65(17):7976-83. PubMed ID: 16140970
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
    Agoulnik IU, Vaid A, Bingman WE, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL.
    Cancer Res; 2005 Sep 01; 65(17):7959-67. PubMed ID: 16140968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.
    Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938
    [Abstract] [Full Text] [Related]

  • 9. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
    Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S.
    Cancer Res; 2005 Nov 01; 65(21):9807-16. PubMed ID: 16267002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G, DiFeo A, Yao S, Banno A, Hod E, Reeves HL, Qiao RF, Camacho-Vanegas O, Levine A, Kirschenbaum A, Chan AM, Friedman SL, Martignetti JA.
    Cancer Res; 2005 Jul 01; 65(13):5761-8. PubMed ID: 15994951
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Androgen deprivation increases p300 expression in prostate cancer cells.
    Heemers HV, Sebo TJ, Debes JD, Regan KM, Raclaw KA, Murphy LM, Hobisch A, Culig Z, Tindall DJ.
    Cancer Res; 2007 Apr 01; 67(7):3422-30. PubMed ID: 17409453
    [Abstract] [Full Text] [Related]

  • 16. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression.
    Vijayvargia R, May MS, Fondell JD.
    Cancer Res; 2007 May 01; 67(9):4034-41. PubMed ID: 17483314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression and function of androgen receptor coactivators in prostate cancer.
    Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobisch A.
    J Steroid Biochem Mol Biol; 2004 Nov 01; 92(4):265-71. PubMed ID: 15663989
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
    Ling YX, Tao J, Fang SF, Hui Z, Fang QR.
    Eur J Cancer Prev; 2011 Jan 01; 20(1):9-17. PubMed ID: 20881502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.